Humedix Co., Ltd. (KOSDAQ:200670)

South Korea · Delayed Price · Currency is KRW

42,550

-1,500 (-3.41%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	110.99B	98.48B	78.62B	64.83B	54.73B
Pharmaceuticals Growth	12.70%	25.26%	21.27%	18.46%	16.11%
Total	110.99B	98.48B	78.62B	64.83B	54.73B
Total Growth	12.70%	25.26%	21.27%	18.46%	16.11%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	85.50B	69.43B	55.44B	47.07B	43.28B
South Korea Growth	23.15%	25.22%	17.79%	8.75%	9.56%
Overseas	25.49B	29.05B	23.18B	17.76B	11.45B
Overseas Growth	-12.27%	25.36%	30.48%	55.19%	50.01%
Total	110.99B	98.48B	78.62B	64.83B	54.73B
Total Growth	12.70%	25.26%	21.27%	18.46%	16.11%

Source: S&P Global Market Intelligence.